■ Antibióticos Nefrotóxicos

– aminoglicosídeos

– antivirais

– anfotericina B

– colistina

– polimixina

– sulfadiazina

– quinolonas

– vancomicina

 

■ Vancomycin nephrotoxicity: vancomycin tubular casts eith characteristic electron microscopic findings

Ngoentra Tantranont, Chizoba Obi, Yosu Luque, Luan D. Truong

Clin Nephrol Case Stud. 2019; 7: 66–72

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921278/

 

■ Factors associated with development of nephrotoxicity in patients treated with vancomycin versus daptomycin for severe gram-positive infections: a practice-based study

José Barberán, José Mensa, Arturo Artero, et al

Rev Esp Quimioter. 2019 Feb; 32(1): 22–30

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372966/

 

■ The nephrotoxicity of vancomycin

EJ Filippone, WK Kraft, JL Farber

Clin Pharmacol Ther. 2017 Sep; 102(3): 459–46

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579760/

 

■ Systematic review and meta-analysis of vancomycin-induced nephrotoxicity associated with dosing schedules that maintain throughs between 15 and 2,0 milligrams per liter

  1. J. van Hal, D. L. Paterson, T. P. Lodise

Antimicrob Agents Chemother. 2013 Feb; 57(2): 734–744

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3553731/

 

■ Urinary biomarkers of aminoglycoside-induced nephrotoxicity in cystic fibrosis: kidney injury molecule-1 and neutrophil gelatinase-associated lipocalin

Stephen J. McWilliam, Daniel J. Antoine, Andrea L. Jorgensen et al

Sci Rep. 2018; 8: 5094

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5865203/

 

■ Potentiating aminoglycoside antibiotics to reduce their toxic side effects

Christopher R. Rosenberg, Xin Fang, Kyle R. Allison

PLoS One. 2020; 15(9): e0237948

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7467299/

 

■ Aminoglycoside-induced nephrotoxicity in children

Stephen J McWilliam, Daniel J Antoine, Rosalind L Smyth, Munir Pirmohamed

Pediatr Nephrol. 2017; 32(11): 2015–2025

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624973/

 

■ A randomized controlled trial of rosuvastatin for the prevention of aminoglycoside-induced kidney toxicity in children with cystic fibrosis

Stephen J. McWilliam, Anna Rosala-Hallas, Ashley P. Jones et al

Sci Rep. 2020; 10: 1796

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000680/

 

■ Nephrotoxicity of ciprofloxacin: five cases and a review of the literature

Meriam Hajji, Hela Jebali, Aymen Mrad, et al

Drug Saf Case Rep. 2018 Dec; 5: 17

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5906393/

 

■ Higher dosage of ciprofloxacin necessary in critically III patients: a new dosing algorithm based on renal function and pathogen susceptibility

Emilie M. Gieling, Eveline Wallenburg, Tim Frenzel, et al

Clin Pharmacol Ther. 2020 Oct; 108(4): 770–774

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7540326/

 

■ Escherichia coli resistance to fluoreoquinolones in community-acquired uncomplicated urinary tract infection in women: a systematic review

Ann E. Stapleton, Florian M. E. Wagenlehner et al

Antimicrob Agents Chemother. 2020 Oct; 64(10): e00862-20

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508571/

 

■ Risk of acute kidney injury associated with the use of fluoroquinolones

Steven T. Bird, Mahyar Etminan, James M. Brophy, et al

CMAJ. 2013 Jul 9; 185(10): E475–E482

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3708027/

 

■ Cefazolin-related acute interstitital nephritis with associated nephrotic-range proteinuria: a case report

Ang Xu, David Hyman, Lee Bach Lu

rug Saf Case Rep. 2018 Dec; 5: 16

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5891510/

 

■ Cefepime induced acute interstitital nephritis – a case report

Kathy Mac, Ruchir Chavada, Sharon Paull, Kenneth Howlin, Jeffrey Wong

BMC Nephrol. 2015; 16: 15

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4359532/

 

■ Molecular mechanisms of colistin-induced nephrotoxicity

Zhibo Gai, Sophia L. Samodelov, Gerd A. Kullak-Ublick, Michele Visentin

Molecules. 2019 Feb; 24(3): 653

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6384669/

 

■ Nephrotoxicity of polymyxins: Is there any difference between colistimethate and polymyxin B?

Alexandre P. Zavascki, Roger L. Nation

 

■ Colistin-induced nephrotoxicity in a tertiary teaching hospital

D A Al-Abdulkarim, O A Alzuwayed, M Al Ammari et al

Saudi Journal of Kidney Disease and Transplantation ,2020, vol 31 (5): 1057-1061

https://www.sjkdt.org/article.asp?issn=1319-2442;year=2020;volume=31;issue=5;spage=1057;epage=1061;aulast=Al-Abdulkarim

 

■  Dr Paulo Fernando Leite

Cardiologia/Prevenção Cardiovascular

Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil

Tel: 33245518

CRMMG: 7026

Email: pfleite1873@gmail.com

Blog Internet Médica – www.internetmedica.com.br

Data: janeiro 2021